Through integrative multiple-omics analysis, we elucidated that ZNF217 exerts its oncogenic role in B-ALL through both CoREST-dependent and CoREST-independent mechanisms. The gene discussed is ZNF217; the disease is precursor B-cell acute lymphoblastic leukemia.